Type 2 diabetic patients with stable angina pectoris who undergo percutaneous coronary intervention
Conditions
Interventions
DPP-4 inhibitor tretment 1 year after measurement of baseline IMR value
no treatment
Sponsors
Cardiovascular Division, Hyogo College of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Stable angina pectoris 2) Type2 diabetes mellitus who are controlled well 3) Culprit lesion involving 75% or more of the stenosis without LAD 4) Successful revascularization of target lesion 5) Patients providing written consent for participattion in this clinical trial on their own volition after receiving a thorough explanation of the study
Exclusion criteria
Exclusion criteria: 1) Target lesion is left main coronary artery 2) Patients on hemodialysis 3) Patients with acute coronary syndorome 4) Patients with contraindication of antiplatelet or anticoagulation drug 5) Patients who are uncontrolled diabetes mellitus 6) Patients who are judged by the principal investigator to be ineligible for enrollment in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in index of microcirculatory index | — |
Secondary
| Measure | Time frame |
|---|---|
| Absolute and percent changes of high-sensitive CRP and adiponectine | — |
Countries
Japan
Contacts
Public ContactMasashi Fukunaga
Hyogo College of Medicine Cardiovascular Division
Outcome results
None listed